CARE Ratings declares interim dividend, sells stakes in CareEdge Global

CARE Ratings Limited reported a net profit of INR 5,720.99 lakhs for the quarter ended September 30, 2025, with total income reaching INR 14,894.79 lakhs. For the half-year ended September 30, 2025, the consolidated net profit stood at INR 8,370.73 lakhs, and total income was INR 25,639.37 lakhs. The board has declared an interim dividend of INR 8 per equity share of face value INR 10 for the financial year 2025-26, with November 19, 2025, set as the record date.

The company also approved the appointment of Dr. Bimal Patel as an additional director (non-executive independent director) effective November 12, 2025, for a three-year term. Furthermore, CARE Ratings will sell up to a 9.9% stake each in its wholly-owned subsidiary, CareEdge Global IFSC Limited (CGIL), to the State Bank of India (SBI) and NSE IFSC Limited (NSEIX) for a total consideration of INR 5.94 crore. Post-sale, CARE Ratings will retain an 80.20% stake, and CGIL will cease to be a wholly-owned subsidiary.

Additionally, 5,000 stock options have been granted to eligible employees under the 'CARE Employee Stock Option Scheme 2020' at an exercise price of INR 1,567, vesting over three years.